Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 89032474

ITGAL, anti-Human, Clone: hu1124 (Efalizumab), Abnova™

Catalog No. 89032474 Shop All Abnova Corporation Products
Change view
Click to view available options
Quantity:
200 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
89-032-474 200 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 89-032-474 Supplier Abnova Corporation Supplier No. RAB00131
Add to Cart
Add to Cart

Description

Monoclonal Antibody

Specifications

Antigen ITGAL
Applications Blocking Assay, Flow Cytometry
Classification Monoclonal
Clone hu1124 (Efalizumab)
Conjugate Unconjugated
Dilution Blocking Flow Cytometry (1 ug/mL) The optimal working dilution should be determined by the end user.
Formulation In PBS, pH 7.2 (0.02% Proclin 300).
Gene integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
Gene Alias CD11A/LFA-1/LFA1A
Gene Symbols ITGAL
Immunogen Original antibody is raised against a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes.
Quantity 200 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 3683
Target Species Human
Content And Storage Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing.
Product Type Antibody
Form Liquid
Isotype IgG κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.